Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer

NCT03456843 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03456843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03456843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 20, 2018
Completion date
March 31, 2027
Enrollment
190 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv prostate adenocarcinoma ajcc v7